'Informed Decision' May Irk Surgeons as It Cuts Costs, Improves Quality
"Eventually you could die"
Makary confesses that as a trainee, he engaged in a practice he called "patient manipulation" as a survival mechanism.
"I was under pressure to get [patients] to sign surgical consents. If a patient asked, 'What if I don't have this done?' I would cut right to the chase and say, 'Eventually you could die.' That was a phrase that circulated a lot among residents."
The idea to get patients to consider their own unique health status before making a decision is, in part, the brainchild of James Weinstein, DO, a spine surgeon and former head of the Dartmouth Institute. He is now President and CEO of Dartmouth-Hitchcock healthcare system.
Just in his field of spine surgery, he says, "we know that in shared decision-making models, when patients are given good information, 30% choose not to have surgery."
Some versions of the concept have been rolled out at Dartmouth for a variety of orthopedic procedures, Weinstein says. All take the surgeon out of the decision-making equation because of obvious conflicts of interest they may have, conscious or unconscious.
Decisions about non-emergent surgeries "should be made at the primary care doctor level. That's what we at Dartmouth do," he says.
Naturally, the idea will get the best reception in healthcare systems with salaried surgeons, like Dartmouth-Hitchcock or Makary's Johns Hopkins.
Several systems, like Intermountain and the Mayo Clinic, are rolling out versions of this model soon. At Mayo Clinic, it's being adopted to help patients choose how to choose medications for their diabetes.
- How Top-Ranked MA Plans Earn Their Stars
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- House Calls Key to Pioneer ACO Success
- How Telehealth Pays Off for Providers, Patients
- 4 Tips for Managing Employed Physicians
- WellPoint Dominates Nearly Half of Markets, AMA Says
- Defensive Medicine Still Prevalent Despite Tort Reform
- CMS Offers Some ACOs $114M for 'Upfront' Costs